Literature DB >> 12414143

Epidemiology, zoonotic aspects, vaccination and control/eradication of brucellosis in India.

G J Renukaradhya1, S Isloor, M Rajasekhar.   

Abstract

In India, brucellosis was first recognised in 1942 and is now endemic throughout the country. The disease is reported in cattle, buffalo, sheep, goats, pigs, dogs and humans. B. abortus biotype-1 in cattle and buffaloes and B. melitensis biotype-1 in sheep, goats and man are the predominant infective biotypes. The long-term serological studies have indicated that 5% of cattle and 3% of buffaloes are infected with brucellosis. Economic losses due to brucellosis in livestock are considerable in an agrarian country like India. There is no organised and effective brucellosis control programme in the country. With the indigenous development of serum and milk based ELISA kits, the population survey of the disease has been undertaken on a large scale in several states and plans for the control of the disease through calf-hood vaccination are being worked out. An innovative approach--Bovine Brucellosis Progressive Control Programme (BBPCP) is targeted to overcome the basic problems of ban on cow slaughter, distress sale of animals following the positive serological diagnosis of brucellosis and absence of a disease control strategy. The work plan for the implementation of BBPCP is presented. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414143     DOI: 10.1016/s0378-1135(02)00253-5

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  44 in total

1.  Rapid detection of Brucella by an automated blood culture system at a tertiary care hospital of north India.

Authors:  Atul Raj; Vikas Gautam; Puneet Kumar Gupta; Sunil Sethi; Sudesh Rana; Pallab Ray
Journal:  Indian J Med Res       Date:  2014-05       Impact factor: 2.375

2.  Immunogenicity and protective potential of a bacterially expressed recombinant dihydrolipoamide succinyltransferase (rE2o) of Brucella abortus in BALB/c mice.

Authors:  Shailendra Kumar Verma; Shikha Jain; Subodh Kumar
Journal:  World J Microbiol Biotechnol       Date:  2012-04-22       Impact factor: 3.312

3.  Real-time PCR carried out on DNA extracted from serum or blood sample is not a good method for surveillance of bovine brucellosis.

Authors:  Arvind Tiwari; Vijai Pal; Prachiti Afley; Deepak Kumar Sharma; Chandra Shekhar Bhatnagar; Bhupendra Bhardwaj; Ganga Prasad Rai; Subodh Kumar
Journal:  Trop Anim Health Prod       Date:  2014-09-04       Impact factor: 1.559

4.  Evaluation of the recombinant 10-kilodalton immunodominant region of the BP26 protein of Brucella abortus for specific diagnosis of bovine brucellosis.

Authors:  Arvind Kumar Tiwari; Subodh Kumar; Vijai Pal; Bhupendra Bhardwaj; Ganga Prasad Rai
Journal:  Clin Vaccine Immunol       Date:  2011-08-18

5.  Brucellosis in Occupationally Exposed Groups.

Authors:  Smita S Mangalgi; Annapurna G Sajjan; Shivajirao T Mohite; Shivali Gajul
Journal:  J Clin Diagn Res       Date:  2016-04-01

6.  Epidemiological Modeling of Bovine Brucellosis in India.

Authors:  Gloria J Kang; L Gunaseelan; Kaja M Abbas
Journal:  Proc IEEE Int Conf Big Data       Date:  2014-10

7.  Herd and individual animal prevalence of bovine brucellosis with associated risk factors on dairy farms in Haryana and Punjab in India.

Authors:  Puran Chand; Rajesh Chhabra
Journal:  Trop Anim Health Prod       Date:  2013-01-25       Impact factor: 1.559

Review 8.  Brucellosis in low-income and middle-income countries.

Authors:  Matthew P Rubach; Jo E B Halliday; Sarah Cleaveland; John A Crump
Journal:  Curr Opin Infect Dis       Date:  2013-10       Impact factor: 4.915

Review 9.  Brucellosis in India - a review.

Authors:  Basappa G Mantur; Satish K Amarnath
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

10.  Multilocus variable number tandem repeat analysis (MLVA)-typing of Brucella abortus isolates of India reveals limited genetic diversity.

Authors:  Maninder Singh; Mohd Ashraf Malik; Dhirender Kumar Singh; Soni Doimari; Rohini Sharma
Journal:  Trop Anim Health Prod       Date:  2019-11-11       Impact factor: 1.559

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.